人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學習資料_第1頁
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學習資料_第2頁
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學習資料_第3頁
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學習資料_第4頁
人體結(jié)構(gòu)與功能 21-Sedative-hypnotics and anti-epileptic,anti-seizure drugs(2)學習資料_第5頁
已閱讀5頁,還剩42頁未讀 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

AntiepilepticandAnticonvulsiveDrugsLouhaiyanInstituteofPharmacologySchoolofMedicineShandongUniversitylouhaiyan@1Section1AntiepilepticDrugs

2Epilepsy(癲癇)3Aseizureistheclinicalmanifestationofasudden,excessiveandsynchronousdischargeoffocalneuronsanddiffusiontonormalneuronaltissues.Epilepsyischaracterizedby

recurrent,suddenandtransientseizures.Definitionofepilepsy

sensorydisorder,behaviordisorder,andpsychotic4Classificationsofseizuretypes1.Partialseizures(局限性發(fā)作)①Simplepartialseizures(單純性局限性發(fā)作)②Complexpartialseizures(復合性局限性發(fā)作)Psychomotorseizures(精神運動性發(fā)作)2.Generalizedseizures(全身性發(fā)作)①Absence(petitmal)seizures(失神性發(fā)作,小發(fā)作)②Myoclonicseizures(肌陣攣性發(fā)作)③Generalizedtonic-clonic(gradmal)seizures(強直-陣攣性發(fā)作,大發(fā)作)④Statusepilepticus

(癲癇持續(xù)狀態(tài))5CauseofepilepsyIdiopathicepilepsyComplicatedGeneticSecondaryepilepsyCNSinfectionTraumaTumorParasitesetc6PathogenesisofepilepsyinitiationandspreadImbalancefunctionofneurotransmittersandinstableneuronalmembrane

7EEGRecordsDuringEpilepticSeizureEpilepsyischaracterizedbyuncontrolledexcessiveactivityofeitherapartorallofthecentralnervoussystem.Grandmalepilepsy:characterizedbyextremeneuronaldischargesinallareasofthebrain,lastfromafewsecondsto3to4minutes.Petitmalepilepsy:Characterizedby3to30secondsofunconsciousnessordiminishedconsciousnessduringwhichthepersonhasseveraltwitch-likecontractionsofthemuscle.8DiagnosisofEpilepsyYesorNo?HistoryClassificationReason?9TreatmentofEpilepsyAim:Keepthepatientfreeofseizures,withnoadverseeffects,notaffectingthelifequality.CauseDrugtreatmentSurgeryorphysicaltherapy101.Blocktheinitiationofabnormalofabnormaldischargefromthefocalarea.2.Preventthespreadofabnormaldischargetoadjacentbrainareas.Mechanismsofantiepilepsydrugs

ActionPatterns:11Mechanismsofantiepilepticdrugs

1.Decreaseactivityofvoltage-dependentNa+channels2.Decreaseactivityofvoltage-dependentCa2+channelsN-type(neuronal);L-type(longlasting)T-type(transient)3.EnhanceGABAergictransmissiondecreasethereuptakeormetabolismofGABAdirectactionontheGABAA-R4.

Diminishglutamatefunction

12

Section2

Commonly-usedantiepilepticdrugs13

phenytoinsodium(苯妥英鈉)

barbiturates:phenbarbital(苯巴比妥)

primidone(撲米酮)

carbamazepine(卡馬西平)

ethosuximide(乙琥胺)

sodiumvalproate(丙戊酸鈉)

benzodiazepines:

diazepam(地西泮)

nitrozepam(硝西泮)

clonazepam(氯硝西泮)

antiepilepsirine(抗癇靈)

newerdrugs:flunarizine(氟桂利嗪)

lamotrigine(拉莫三嗪)

topiramate(托吡酯)14

1.PhenytoinSodium

(苯妥英鈉,Dilantin,大侖?。?5

【Pharmacologicalactions】CannotinhibitthedischargeofneuroninfocusPreventthediffusioninnormalneuroninhibitposttetanic

potentiation(PTP,強直后增強):反復高頻電刺激(強直刺激)突觸前神經(jīng)纖維,引起突觸傳遞易化,使突觸后纖維反應(yīng)增強的現(xiàn)象16Membrane-stabilizingfunction1.

blockvoltage-sensitiveNa+channel2.

blockvoltage-sensitiveCa2+channel(Ltype,Ntype)

3.inhibittheactivityofcalmodulin

kinase

(鈣調(diào)素激酶)presynapticmembrane—Glurelease↓postsynapticmembrane—depolarization↓【Mechanismsofaction】171.Epilepsy:

generalizedtonic-clonicseizures(gradmal)

andpartialseizures

(firstchoice)

except

absenceseizures(petitmal)

(noeffect,evenexacerbatedisease)

【clinicaluses】attention:slowonsetphenobabital→phenytoinsodium183.

Ventriculararrhythmia(心律失常):

cardiacglycosideinduced(強心苷中毒)-firstchoice2.Neuralgias:

trigeminalneuralgia(三叉神經(jīng)痛)glossopharyngealneuralgia(舌咽神經(jīng)痛)【clinicaluses】191.Absorptionstrongirritation(alkaline,pH=10.4),notim.Oral:unpredictable,slowonset

Css:6-10d(10-20ug/ml)iv.forstatusepilepticus

【Pharmacokinetics】20【Pharmacokinetics】2.Metabolism:mainlyinliver,hepaticenzymeinduction

≤10g/ml:first-ordereliminationkinetics,

t1/2=20h

≥10g/ml:zero-ordereliminationkinetics,t1/2=60hmonitorblooddrugconcentration(10-20g/ml)3.C=10g/ml(anti-epilepsy)

C=20g/ml(intoxication)211.Localstimulation①gastrointestinalirritation②phlebitis(靜脈炎)③gingivalhyperplasia20%AdverseReactions222.CNSsymptoms

20g/ml:dizziness,ataxia﹥40g/ml:psychoticdisiorder﹥50g/ml:coma

233.Megaloblasticanemia防治:甲酰四氫葉酸4.Hypocalcemia,

osteomalacia(軟骨癥)

rachitis(佝僂病):children防治:VitD24AdverseReactions5.Allergyskinrash

agranulocytosis(粒細胞缺乏)

thrombocytopenia(血小板減少)

aplasticanemia(再生障礙性貧血)

hepaticlesion

256.Teratogenesis

【AdverseReactions】fetalhydantoinsyndrome(胎兒妥因綜合征)26

芬蘭1980~1998年,研究人員追蹤了一家產(chǎn)科診所中970位懷孕的癲癇婦女,其中有740位在懷孕初期(前3個月)服用抗癲癇藥物,另外239位則無。結(jié)果在這些服用抗癲癇藥物的懷孕婦女中,共產(chǎn)下28個嚴重畸形兒(3.8%),未服用抗癲癇藥物組產(chǎn)下2個嚴重畸形兒(0.8%;P=0.02)27

2.Phenobarbital(苯巴比妥)【Pharmacologicalactionsandclinicaluses】1.rapidonset2.usedforgeneralizedtonic-clonicseizuresand

statusepilepticus(iv),butnotfirstchoice

Mechanisms:inhibitinitiationandspreadofabnormaldischarge

increaseGABAinducedCl-in(extendopeningtime)inhibitexcitatoryneurotransmitter-mediatedeffecthighdoseinhibitNa+,Ca2+(LandN-type)channel28

3.Primidone(撲米酮)activemetabolites:

phenobarbital

phenylethylmalonamides(PEMA,苯乙基丙二酰胺)294.Ethosuximide(乙琥胺)Theonlyindication:

absenceepilepsy-firstchoiceMechanisms:inhibittheT-typeCa2+currentin

thalamicneurons

301.Diazepam:statusepilepticus-firstchoice

(iv,slow)2.Nitrazepam(硝西泮):absenceseizure,myoclonicseizure,infantilespasm3.Clonazepam(氯硝西泮):broad-spectrum5.Benzodiazepines316.SodiumValproate

(丙戊酸鈉)Uses:Broad-spectrumLesseffectiveforgradmalthanphenytoinand

phenobarbital

Similareffectiveforpartialmalwithcarbamazepine

Moreeffectivethanethosuximideforabsenceseizurebutnotthefirstchoiceduetohepatictoxicity.Gradmalcombinedwithabsenceseizure-firstchoice

Refractoryepilepsy(頑固性癲癇)32

Mechanisms:inhibitdischargespreadenhanceGABAfunction:

inhibitNa+,T-typeCa2+channel33SodiumValproateGADGABA-TglutamicacidsuccinicacidsemialdehydeGABA+-6.SodiumValproate

(丙戊酸鈉)GAD:谷氨酸脫羧酶GABA-T:谷氨酸轉(zhuǎn)氨酶琥珀酸半醛34AdverseReactionsGastrointestinalreactionsandCNSreactionsLiverinjury:25%routineexaminationTeratogenesis357.Carbamazepine(卡馬西平)【Pharmacologicalactionsandclinicaluses】1.Epilepsy:broadspectrum

gradmal,complexpartialseizures-firstchoice

nogoodforabsenceepilepsy2.Neuralgias:moreeffectivethanphenytoinMechanismsinhibitNa+、Ca2+channelenhanceGABAinhibitoryfunction3.Diabetesinsipidus

(尿崩癥)

4.Maniaanddepression(躁狂抑郁癥)36尿崩癥AVP(argininevasopressin):精氨酸加壓素ADH(antidiuretichormone):抗利尿激素卡馬西平:促進ADH分泌病因:下丘腦-神經(jīng)垂體部位的病變↓ADH(AVP),

腎小管重吸收功能障礙多尿、煩渴、多飲與低比重尿37OthersAntiepilepsirin(抗癇靈)flunarizine(氟桂利嗪)Lamotrigine(拉莫三嗪)Topiramate(托吡酯,妥泰)newer38Principles1.Selectdrugaccordingtoepilepsyclassification2.Increasedosegradually3.Transitionaldrugchange:addaseconddrugbeforestopthefirstone4.Withdrawslowly(halfyear)5.Monitorhemogram(血象)andliverfunction6.Pregnantwomanshouldtakecaution39對癥選藥原則癲癇類型首選藥物大發(fā)作和局限性發(fā)作苯妥英鈉小發(fā)作乙琥胺大發(fā)作和精神運動型性發(fā)作卡馬西平癲癇持續(xù)狀態(tài)地西泮iv大發(fā)作合并小發(fā)作丙戊酸鈉40++++++++++41Principles1.對癥選藥2.劑量漸增3.先加后撤4.久用慢停5.肝功血象6.孕婦慎用42Section3Anticonvulsants

BarbituratesBenzodiazepinesChloralhydrateMagnesiumSulfate43MagnesiumSulfatedifferentadministrationroutes→differenteffects1.oral—catharsis,cholagogue(導瀉、利膽)2.external—dephlogisticate(消炎)3.ivorim—

anticonvulsive:relaxantofskeletalmuscle

BPlowering:inhibitcardiacmuscle,dilateVSM

Mechanism:calciumantagonismUses:

hypertensivecrisis,convulsion44MagnesiumSulfatetendonreflex(腱反射)Overdose:respiratoryinhibitionandhypotensionTreatment:artificialbreathingivcalciumchlorideorcalciumgluconate4546CasehistoryGabyisa22

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論